Revised due to typo error in date
Pharmaceutical Manufacturing Project at Nava Raipur Pharma Park.
Scrutinizer's Report
Outcome for Postal Ballot
News paper Publication
Press Release on Audited Financial Results for Quarter and Year ended 31 March 2026
Non-Applicability of Regulations 32 of SEBI (LODR)
Financial results for quarterly & year ended 31st March 2026.
Outcome of board meeting
Outcome of board meeting
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.15 | 19.76 | 30.42 | 35.41 |
| YOY Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.64 | 0.02 | 0.18 | 0.18 | 0.11 |
| Total Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.64 | 7.17 | 19.94 | 30.60 | 35.52 |
| Total Expenses + | 0.12 | 0.13 | 0.11 | 0.37 | 0.55 | 0.40 | 0.54 | 0.25 | 7.67 | 17.74 | 28.00 | 34.10 |
| Cost of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Benefit Expense | 0.07 | 0.11 | 0.09 | 0.12 | 0.11 | 0.14 | 0.19 | 0.25 | 0.38 | 0.36 | 0.39 | 0.35 |
| Other Expenses | 0.05 | 0.02 | 0.02 | 0.25 | 0.44 | 0.25 | 0.34 | -0.01 | 0.53 | 0.84 | 0.28 | 0.66 |
| Operating Profit | -0.12 | -0.13 | -0.11 | -0.37 | -0.55 | -0.40 | -0.54 | -0.25 | -0.52 | 2.03 | 2.42 | 1.31 |
| OPM % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -7.2% | 10.3% | 7.9% | 3.7% |
| Profit Before Tax + | -0.12 | -0.13 | -0.11 | -0.37 | -0.55 | -0.40 | -0.54 | 0.39 | -0.50 | 2.21 | 2.60 | 1.42 |
| Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.37 | 0.03 | 0.36 |
| Tax % | - | - | - | - | - | - | - | -0.3% | - | 16.7% | 1.3% | 25.1% |
| Profit After Tax | -0.12 | -0.13 | -0.11 | -0.37 | -0.55 | -0.40 | -0.54 | 0.39 | -0.50 | 1.84 | 2.57 | 1.06 |
| EPS (Basic) | -0.28 | -0.31 | -0.25 | -0.84 | -1.24 | -3.94 | -0.53 | 0.21 | -0.21 | 0.77 | 1.08 | 0.45 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 92.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| YOY Revenue Growth % | - | - | - | - | - | - |
| Other Income | 0.49 | 0.64 | 0.00 | 0.01 | 0.00 | 0.00 |
| Total Income | 93.23 | 0.64 | 0.00 | 0.01 | 0.00 | 0.00 |
| Total Expenses + | 87.51 | 1.73 | 0.74 | 0.34 | 0.19 | 0.18 |
| Employee Benefit Expense | 1.47 | 0.69 | 0.40 | 0.23 | 0.09 | 0.05 |
| Other Expenses | 2.28 | 1.03 | 0.34 | 0.11 | 0.09 | 0.10 |
| Operating Profit | 5.23 | -1.73 | -0.74 | -0.34 | -0.19 | -0.18 |
| OPM % | 5.6% | 0% | 0% | 0% | 0% | 0% |
| Profit Before Exceptional | 5.72 | -1.09 | -0.74 | -0.34 | -0.19 | -0.18 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax + | 5.72 | -1.09 | -0.74 | -0.34 | -0.19 | -0.18 |
| Tax Expense | 0.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax % | 13.3% | - | - | - | - | - |
| Profit After Tax | 4.96 | -1.09 | -0.74 | -0.34 | -0.19 | -0.18 |
| EPS (Basic) | 2.09 | -0.99 | -1.68 | -0.77 | -0.42 | -0.41 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Non-Current Assets + | 2.21 | 0.07 | 0.02 | 0.02 | 0.02 | 0.03 |
| Property, Plant & Equipment | 0.70 | 0.04 | 0.00 | 0.00 | 0.00 | 0.01 |
| Capital Work in Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Assets + | 84.06 | 25.16 | 4.55 | 0.68 | 0.71 | 1.37 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Trade Receivables | 70.78 | 0.60 | 0.60 | 0.60 | 0.60 | 1.25 |
| Cash and Cash Equivalents | 10.58 | 21.30 | 0.12 | 0.00 | 0.00 | 0.01 |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | ||||||
| Total Equity | 29.61 | 24.65 | 1.08 | -0.73 | -0.39 | -0.21 |
| Equity Share Capital | 23.71 | 23.71 | 4.39 | 4.39 | 4.39 | 4.39 |
| Other Equity | 5.91 | 0.95 | -3.31 | -5.12 | -4.78 | -4.60 |
| Non-Current Liabilities | 0.12 | 0.00 | 0.00 | 1.38 | 0.00 | 0.00 |
| Current Liabilities | 56.54 | 0.57 | 3.49 | 0.05 | 1.12 | 1.61 |
| Total Liabilities | 56.66 | 0.57 | 3.49 | 1.43 | 1.12 | 1.61 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activities | -9.47 | -4.71 | -0.21 | -0.35 | -0.13 | -0.25 |
| Cash from Investing Activities | -1.36 | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 0.12 | 23.39 | 2.88 | 0.36 | 0.13 | 0.25 |
| Net Increase/Decrease in Cash | -10.72 | 18.63 | 2.67 | 0.00 | -0.01 | 0.00 |